StonvexLoading…
StonvexStonvexStonvexCore line items from INVU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.90M | $36.26M | $29.11M | $20.05M |
Operating Income | $-2.79M | $-8.26M | $-1.47M | $-430.17K |
Net Income | $-3.89M | $-8.91M | $-1.11M | $-260.37K |
EPS (Diluted) | $0.00 | $-0.01 | $0.00 | $0.00 |
Total Assets | $17.51M | $21.50M | $27.49M | $29.54M |
Total Liabilities | $12.32M | $12.57M | $10.84M | $12.14M |
Cash & Equivalents | $4.52M | $9.99M | $15.08M | $16.16M |
Free Cash Flow OCF − CapEx | $-2.87M | $-4.24M | $-3.62M | $-3.86M |
Shares Outstanding | 1.85B | 1.85B | 1.85B | 1.86B |